Palmitoyl hexapeptide-12Cosmetic ingredient
Palmitoyl hexapeptide-12 is a cosmetic peptide with an attached fatty chain. Its sequence is associated with elastin-related biology, which has led to interest in skin texture and elasticity.
What is Palmitoyl hexapeptide-12?
Palmitoyl hexapeptide-12 is a cosmetic peptide with an attached fatty chain and a sequence related to elastin biology. It is used in products targeting texture and elasticity.
How it works
Elastin-related fragments can interact with cells involved in the tissue environment. Palmitoylation changes the ingredient's physical properties, but does not demonstrate that a cream replaces elastin or reaches a particular skin compartment.
Effects studied
Skin texture and elasticity
The retained sources concern mechanistic and safety-oriented research. These are not interchangeable with a controlled human trial showing improved elasticity or reduced wrinkle depth. 1 2
Evidence: Mechanistic and safety research leads; visible clinical benefit is not quantified here.
What does the evidence show?
The archive includes mechanistic and safety-oriented research leads. These answer different questions from a controlled trial showing a visible cosmetic improvement.
An ingredient built around a structural clue
Elastin contributes to the way tissues stretch and return towards their original shape. Fragments related to structural proteins can also interact with cells. That makes an elastin-inspired peptide scientifically interesting, but does not mean a topical formula simply replaces lost elastin or restores youthful skin.
The attached fatty chain matters
Palmitoylation changes the physical properties of a peptide and its behaviour in a cosmetic formulation. It is often discussed in relation to delivery. Whether a useful amount reaches a particular skin compartment still depends on the preparation and needs evidence rather than an assumption based on the chemistry.
Safety research and benefit research are separate
A toxicity study cannot establish that a cream reduces wrinkles. A short study of appearance, in turn, may not fully describe tolerability with prolonged use. The retained references need to be interpreted according to the question each investigated. 1 2
What to expect from a product claim
To assess a product claim, look for the measured change, comparison and time period. A phrase such as “repairing the matrix” leaves these details unclear. Moisturisers may contribute to a smoother feel, and irritation can depend on the whole formula. Both benefit and tolerability therefore need to be assessed in the finished product.
Safety & status
Tolerability depends on the finished formula and use conditions. A toxicity study answers a safety question, not whether the product delivers its cosmetic promise.
Country and product status
This page describes a cosmetic ingredient and its research context. Permitted claims and product availability in Germany and Switzerland need a local check. An ingredient listing does not establish approval to treat a medical condition.
Frequently asked questions
Does this ingredient add elastin to the skin?
No. It is an elastin-related peptide investigated for signalling, not a replacement layer of elastin.
Does the fatty chain guarantee better penetration?
No. Delivery still depends on the preparation and requires evidence for the relevant skin layer.
Further reading
Sources
This entry was rewritten from our research archive. References below are reading leads unless a completed check is explicitly noted; a full independent evidence and regulatory review is still pending.
- Palmitoyl hexapeptide-12: paper 10.1021/acsabm.4c01816 Research reference · Retained archive reference; not independently checked for this draft.
- Palmitoyl hexapeptide-12: paper 10.1016/j.crtox.2026.100291 Research reference · Retained archive reference; not independently checked for this draft.
Research provenance
This name was discovered in the Superpower peptide index, archived 26 October 2026. Its ratings and reviewer attribution have not been adopted as our own. The archive informed this original editorial draft; independent source review is still pending.